Paulo A Palhares de Miranda (Paulo Miranda)

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Chronic Lymphocytic Leukemia

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Matthew S Davids, Jeff P Sharman, Paolo Ghia, Jennifer A Woyach, Toby Andrew Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo A Palhares de Miranda, Mina Shahkarami, Anna Maria Butturini, Ugochinyere Emeribe, John C Byrd
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: Pooled analysis of 5 clinical trials. Blood advances (2024)
Matthew S Davids, Jeff P Sharman, Paolo Ghia, Jennifer A Woyach, Toby Andrew Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo A Palhares de Miranda, Mina Shahkarami, Anna Butturini, Ugochinyere Emeribe, John C Byrd
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials. Blood advances 8 (13) (2024)
Matthew S Davids, Jeff P Sharman, Paolo Ghia, Jennifer A Woyach, Toby Andrew Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo A Palhares de Miranda, Mina Shahkarami, Anna Butturini, Ugochinyere Emeribe, John C Byrd
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials. Blood advances 8 (13) (2024)
Matthew S Davids, Jeff P Sharman, Paolo Ghia, Jennifer A Woyach, Toby Andrew Eyre, Wojciech Jurczak, Tanya Siddiqi, Paulo A Palhares de Miranda, Mina Shahkarami, Anna Butturini, Ugochinyere Emeribe, John C Byrd
Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL: pooled analysis of 5 clinical trials. Blood advances 8 (13) (2024)